Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis

OBJECTIVE: Iodine-123 metaiodobenzylguanidine (MIBG) cardiac scintigraphy has shown the potential to discriminate dementia with Lewy bodies (DLB) from Alzheimer’s disease (AD). However, these studies did not reflect clinical practice, as patients with ischemic heart disease, heart failure, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Slaets, Sylvie, Van Acker, Frank, Versijpt, Jan, Hauth, Lothar, Goeman, Johan, Martin, Jean-Jacques, De Deyn, Peter Paul, Engelborghs, Sebastiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657469/
https://www.ncbi.nlm.nih.gov/pubmed/25363642
http://dx.doi.org/10.1002/gps.4229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657469/
https://www.ncbi.nlm.nih.gov/pubmed/25363642
http://dx.doi.org/10.1002/gps.4229

Ejemplares similares